title: Stevens-Johnson syndrome after amifostine during radiotherapy.
authors.affiliation: Department of Internal Medicine, University Hospital Purpan, Toulouse cedex, France, the Burn Center, University Hospital, Bordeaux cedex, France. astudillo.l@chu-toulouse.fr
authors.forename: Leonardo
authors.initials: L
authors.lastname: Astudillo
authors.forename: Boujemaa
authors.initials: B
authors.lastname: Maachi
authors.forename: Ahmed
authors.initials: A
authors.lastname: Benyoucef
authors.forename: Xavier
authors.initials: X
authors.lastname: Game
authors.forename: Michel
authors.initials: M
authors.lastname: Rives
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Bachaud
mesh_terms: D004999:Amifostine / Q000008:administration & dosage / Q000009:adverse effects*; D002277:Carcinoma / Q000532:radiotherapy; D006801:Humans; D007275:Injections, Intravenous; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D014062:Tongue Neoplasms / Q000532:radiotherapy; D014987:Xerostomia / Q000517:prevention & control
chemical_list: D011837:Radiation-Protective Agents; D004999:Amifostine